Our Mission:

Ensure that essential
generic medications are
available & affordable
to everyone.

Civica Rx is a new enterprise designed to reduce chronic generic drug shortages that have become a national crisis and have negatively impacted patient care for over a decade…

Civica Rx exists in the public interest as a non-profit, non-stock corporation committed to stabilizing supply of essential generic medications in a hospital setting…

Civica Rx was founded by leading U.S. health systems concerned about predatory pricing and drug shortages and philanthropic organizations passionate about improving healthcare…

Civica Rx will act in the best interest of patients to eliminate uncertainty in the generic drug supply chain through long-term contracts with the health system members who have joined Civica Rx as well as its manufacturing partners…

Civica Rx is committed to transparency, will offer fair and sustainable prices, and will ensure it has dedicated manufacturing capacity for the medications that are most desperately needed in hospitals across the country.

Recent News

Commentary from Civica Rx CEO Martin VanTrieste: We are halfway through Civica Rx’s first year. When I reflect on all that has happened since our company’s launch in September 2018, I am proud of what we have accomplished and more motivated than ever to deliver on our mission of making essential generic medications accessible...

Salt Lake City, UT, February 16, 2019 – Civica Rx is proud to announce that Heather Wall, Chief Commercial Officer, has been recognized by Modern Healthcare as one of 2019’s Women Leaders to Watch in Healthcare. The profiles of all the winners are featured in the February 18, 2019 print issue of Modern Healthcare...

Posts navigation

Civica will partner with healthcare systems to ensure that generic drugs are affordable and available as soon as possible.

We will partner with hospitals and healthcare systems to (1) prioritize production of generic drugs and (2) purchase Civica generic drugs, based on hospital system’s clinical needs.

We will create market stability by procuring or manufacturing the products required by our hospital systems

We will guarantee volumes for our hospitals and health system partners for each drug we manufacture

Civica will focus on bringing value — in supply, quality, and price — to the market

We will establish long-term partnerships that will allow us to guarantee predictable, long-term supply

We will provide our suppliers with long-term, predictable volumes

We will work with trusted, FDA-approved manufacturers with high-quality track records. We will embed a collaborative, rigorous quality assurance process with each partner and will have a single price point for each drug, regardless of health system size

We will assure that our prices are transparent and competitive

Civica will serve as a check in the generic manufacturing industry

We will fix broken markets by applying for Abbreviated New Drug Applications (ANDA) for each drug we manufacture

We will have the R&D expertise necessary to enter identified drug markets and develop medications that our patients need

We will partner with our governmental and regulatory agencies to assure we are working together in a way that benefits our patients